Organoid technology using Lgr5+ stem cells to develop mini-organs will open up a whole range of opportunities. Learn more about how these cultured mini-organs could replace transplant organs from donors and hold promise in gene therapy.
Click here to join Megan Riehl, PsyD, in a wellness moment.
Hear how biologic and immunomodulator therapies may impact outcomes in IBD and COVID-19. Learn the latest on pausing and resuming therapies, how to incorporate novel biomarkers to monitor disease activity, and when to consider therapy de-escalation.
Understand the pathogenesis of common Crohn’s disease complications. Novel data will be presented on how fistulizing Crohn’s disease develops and what are targetable mechanisms of stricturing Crohn’s disease.
Review management of mild Crohn’s and ulcerative colitis cases that come up frequently in clinical practice.
Review multidisciplinary management of difficult cases that come up frequently in clinical practice: